PharVision Advisers’s Fortinet FTNT Stock Holding History

PharVision Advisers’s Portfolio FTNT Stock Details FTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,397	Closed	-$202K	–	799
2025 Q3	$202K	Buy	+2,397	New	+$214K	0.11%	516

Other funds holding FTNT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

PharVision Advisers's FTNT Position: Q4 2025 in Review

PharVision Advisers sold out of Fortinet (FTNT) in Q4 2025, closing a stake of 2,397 shares — an estimated $202K sold.

PharVision Advisers first reported a position in FTNT in Q3 2025 and held it in 1 quarter. The position peaked at $202K in Q3 2025. 1,328 funds tracked by Wall St. Rank hold FTNT as of Q4 2025.

PharVision Advisers reported no remaining Fortinet position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 2,397 Fortinet shares in Q4 2025, an estimated $202K.
PharVision Advisers first reported a position in Fortinet in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Fortinet position peaked at $202K in Q3 2025.
1,328 funds tracked by Wall St. Rank held Fortinet as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.